In addition, MAT2A has been identified as a critical enzyme in CSCs, MLL-r leukemias, and cancers that lack methylthioadenosine-phosphorylase (MTAP), which accounts for 15% of all cancers [8, 18, 42, 43]. Here, MTAP is linked to cancer.